Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics

NCT00486291 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: VI-0521
DRUG: Placebo

Sponsor

VIVUS LLC

Collaborators

[object Object]